News GlaxoSmithKline plc Liquidnet

Stocks

GSK

GB0009252882

Pharmaceuticals

Delayed Liquidnet			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

09:55am	Pharma sector doubles down on AI to slash costs, timelines	RE
03:00am	UK inflation rises; Barratt cuts completions outlook	AN

All News

Mentions Relevance

01:00am	AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down	MT
09-15	GSK plc Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 01:05 PM
09-15	GSK plc: Priced for the storm, being built for thereafter
09-15	GSK Upgraded to Buy as Berenberg Notes Pipeline Momentum; Price Target Raised	MT
09-15	Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.	BU
09-15	Berenberg Upgrades GSK to Buy, Raises PT	MT
09-15	GSK to Acquire Experimental Blood Cancer Therapy From Chimagen in $750 Million Deal	MT
09-15	Berenberg Upgrades GSK to Buy From Hold, Raises Price Target to $60 From $54	MT
09-15	Berenberg likes GSK; Deutsche Bank lifts Astra	AN
09-15	GSK agrees up to USD750 million deal for blood cancer-targeting drug	AN
09-15	GSK plc : Deutsche Bank remains Neutral	ZD
09-15	GSK Agrees to Buy Potential Blood Cancer Treatment for Up to $750 Million	MT
09-15	GSK in T-cell deal; Kier puts brakes on Property arm	AN
09-15	GSK to Buy Antibody Treatment From Chimagen for Up to $750 Million	DJ
09-15	GSK plc : Berenberg gives a Buy rating	ZD
09-15	GSK to Acquire Chimagen Biosciences' T-Cell Engager Program for Up to $750 Million	MT
09-15	GSK : to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences	PU
09-15	GSK strikes up to $750 million deal for cancer-targeting drug	RE
09-14	UK Shares Rise Ahead of BoE Rate Decision; GSK Gains on Lung Cancer Data	MT
09-14	GSK Plc Presents Positive Registrational Data To Potentially Expand Jideytro (Zidesamtinib) To First-Line ROS1-Positive Non-Small Cell Lung Cancer	CI
09-14	GSK announces positive data from two clinical trials
09-14	GSK plc : Gets a Sell rating from JP Morgan	ZD
09-14	GSK PLC Announces Positive Phase III Overall Survival Data For Ris-Rez In Relapsed Small Cell Lung Cancer In China	CI
09-14	GSK plc : JP Morgan reiterates its Sell rating	ZD
09-14	GSK plc : Jefferies keeps its Buy rating	ZD